LeMaitre Vascular: The Compounder Keeps Compounding — Buy the Pullback for a Mid‑Cycle Upside
LeMaitre Vascular is a high‑margin, consistently growing specialist in peripheral vascular devices. Recent tempo of innovation, 70% gross margins in Q2 2025 and improving free cash flow make the business a compounding story. The stock has run hard into a 52‑week high but pulled back intraday; this trade idea buys the dip with tight risk controls an…